TrialInternational journal of radiation oncology, biology, physics2013

Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.

Joseph M Herman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.